<p>Ms. Sanah Jowhari at TheraCarb, a biotechnology company in Canada, will apply polymer-based drug technology to capture and remove the Cholera toxin from the body of a host, and validate an approach to developing a viable drug candidate for Cholera.</p>


Ms. Sanah Jowhari at TheraCarb, a biotechnology company in Canada, will apply polymer-based drug technology to capture and remove the Cholera toxin from the body of a host, and validate an approach to developing a viable drug candidate for Cholera.

Testing of a Therapeutic PolyBAIT Concept for In Vivo Protection Against Cholera Toxin

Great ideas come from everywhere.

Sign up for email updates of the latest grant opportunities and awards.

View the Grand Challenges partnership network

.css-1nxq281{overflow:hidden;display:inline-block;}.css-1nxq281 span{display:inline-block;}Great ideas come from everywhere.

Sign up for email updates of the latest grant opportunities and awards.

View the Grand Challenges partnership network

Great ideas come from everywhere.